Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.6.1.23: dUTP diphosphatase

This is an abbreviated version!
For detailed information about dUTP diphosphatase, go to the full flat file.

Word Map on EC 3.6.1.23

Reaction

dUTP
+
H2O
=
dUMP
+
diphosphate

Synonyms

DCD-DUT, dCTP deaminase-dUTPase, dCTP deaminase:dUTPase, deoxyuridine 5'-triphosphate, deoxyuridine 5'-triphosphate nucleotide hydrolase, deoxyuridine 5'-triphosphate nucleotidohydrolase, deoxyuridine 5'-triphosphate pyrophosphatase, deoxyuridine 50-triphosphate nucleotidohydrolase, deoxyuridine 5’-triphosphate nucleotidohydrolase, deoxyuridine nucleotidohydrolase, deoxyuridine triphosphatase, deoxyuridine triphosphate nucleotidohydrolase, deoxyuridine triphosphate pyrophosphatase, deoxyuridine-5'-triphosphate nucleotidohydrolase, deoxyuridine-triphosphate pyrophosphatase, desoxyuridine 5'-triphosphatase, desoxyuridine 5'-triphosphate nucleotidohydrolase, desoxyuridine-triphosphatase, DURP, DUT, DUT-N, DUT1, dUTP nucleotidohydrolase, dUTP pyrophosphatase, dUTPae, dUTPase, dUTPase-dUDPase, dUTPase-related protein, E165R, More, ORF 54, ORF8, P18, PIP4, Pr95, STSV2_30, Tb927.7.5160, U45, YncF, YosS

ECTree

     3 Hydrolases
         3.6 Acting on acid anhydrides
             3.6.1 In phosphorus-containing anhydrides
                3.6.1.23 dUTP diphosphatase

IC50 Value

IC50 Value on EC 3.6.1.23 - dUTP diphosphatase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.000026
(E)-3-(2,2-difluoroethoxy)-N-(7-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methylhept-5-en-2-yl)benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000033
(E)-3-(cyclopentyloxy)-N-(7-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methylhept-5-en-2-yl)benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000028
(E)-3-(cyclopropylmethoxy)-N-(7-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methylhept-5-en-2-yl)benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00034
(E)-N-(7-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methylhept-5-en-2-yl)-3-methoxybenzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0016
(E)-N-(7-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methylhept-5-en-2-yl)benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.01
(R)-1-(4-(2-(hydroxydiphenylmethyl)-pyrrolidin-1-yl)-4-oxobutyl)pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00041
(R)-N-(1-(3-(2,2-difluoroethoxy)phenyl)ethyl)-4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00043
(R)-N-(1-(3-(cyclopentyloxy)phenyl)ethyl)-4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00082
(R)-N-(1-(3-(cyclopropylmethoxy)phenyl)ethyl)-4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000082
(R,E)-N-(1-(3-(2,2-difluoroethoxy)phenyl)ethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)pent-3-ene-1-sulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000041
(R,E)-N-(1-(3-(cyclopentyloxy)phenyl)ethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)pent-3-ene-1-sulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000039
(R,E)-N-(1-(3-(cyclopropylmethoxy)phenyl)ethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)pent-3-ene-1-sulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.001
1-(3-[[(2S)-2-[hydroxy[bis(2-methoxyphenyl)]methyl]pyrrolidin-1-yl]sulfonyl]propyl)pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.001 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.001
1-(3-[[(2S)-2-[hydroxy[bis(3-methoxyphenyl)]methyl]pyrrolidin-1-yl]sulfonyl]propyl)pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.001 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00058
1-(4-[(2S)-2-[bis(3-chlorophenyl)(hydroxy)methyl]pyrrolidin-1-yl]-4-oxobutyl)pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00035
1-(4-[(2S)-2-[bis(3-fluorophenyl)(hydroxy)methyl]pyrrolidin-1-yl]-4-oxobutyl)pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.001
1-(4-[(2S)-2-[bis(4-chlorophenyl)(hydroxy)methyl]pyrrolidin-1-yl]-4-oxobutyl)pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.001 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0006
1-(4-[(2S)-2-[bis(4-fluorophenyl)(hydroxy)methyl]pyrrolidin-1-yl]-4-oxobutyl)pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0073 - 0.03
1-[3-(4-benzylpiperidin-1-yl)-3-oxopropyl]pyrimidine-2,4(1H,3H)-dione
0.0094
1-[3-([(2R)-2-[hydroxy(diphenyl)methyl]pyrrolidin-1-yl]sulfonyl)propyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00028
1-[3-([(2S)-2-[bis(3-fluorophenyl)(hydroxy)methyl]pyrrolidin-1-yl]sulfonyl)propyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00031
1-[3-([(2S)-2-[bis(4-fluorophenyl)(hydroxy)methyl]pyrrolidin-1-yl]sulfonyl)propyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.001
1-[3-[(2S)-2-(diphenylmethyl)pyrrolidin-1-yl]-3-oxopropyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.001 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00015
1-[4-[(2S)-2-(diphenylmethyl)pyrrolidin-1-yl]-4-oxobutyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.001
1-[4-[(2S)-2-[bis[2-(benzyloxy)phenyl](hydroxy)methyl]pyrrolidin-1-yl]-4-oxobutyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.001 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.001
1-[4-[(2S)-2-[bis[3-(benzyloxy)phenyl](hydroxy)methyl]pyrrolidin-1-yl]-4-oxobutyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.001 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.001
1-[4-[(2S)-2-[bis[4-(benzyloxy)phenyl](hydroxy)methyl]pyrrolidin-1-yl]-4-oxobutyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.001 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00023
1-[4-[(2S)-2-[hydroxy[di(thiophen-3-yl)]methyl]pyrrolidin-1-yl]-4-oxobutyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0042
1-[N-(2-triphenylmethylaminoethyl)-acetamide]uracil
Plasmodium falciparum
-
-
0.0025
1-[N-(3-triphenylmethylaminopropyl)-acetamide]uracil
Plasmodium falciparum
-
-
0.0029
1-[N-(4-triphenylmethylaminobutyl)-acetamide]uracil
Plasmodium falciparum
-
above
0.0039
1-[N-(triphenylmethyl) diaminodi(n-propyl) acetamide]uracil
Plasmodium falciparum
-
above
0.0045
1-[N-(triphenylmethylaminoethyl)-N-(aminoethyl) acetamide]uracil
Plasmodium falciparum
-
above
0.083
1-[N-hydroxyethyl-N-(triphenylmethylamino) ethyl-acetamide]uracil
Plasmodium falciparum
-
above
0.3
1-[[2-(trityloxy)ethoxy]methyl]pyrimidine-2,4(1H,3H)-dione
Homo sapiens
IC50 above 0.3 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0053
2',3',5'-trideoxy-3'-fluoro-5'-(tritylamino)uridine
Plasmodium falciparum
-
activity against the parasites with IC50: 0.0053 mM
0.002
2',3'-dideoxy-3'-fluoro-5'-O-trityluridine
Plasmodium falciparum
-
activity against the parasites with IC50: 0.0020 mM, binding structure involving Tyr112, Ile117, Ile108, and Asn103, overview
0.0045
2',5'-dideoxy-5'-(tritylamino)uridine
Plasmodium falciparum
-
activity against the parasites with IC50: 0.0045 mM
0.0011
2'-deoxy-5'-O-(triphenylsilyl)uridine
Plasmodium falciparum
-
activity against the parasites with IC50: 0.0011 mM
0.006
2'-deoxy-5'-O-trityluridine
Plasmodium falciparum
-
activity against the parasites with IC50: 0.006 mM
0.013
2'-deoxy-5'-O-[tris(1-methylethoxy)silyl]uridine
Plasmodium falciparum
-
activity against the parasites with IC50: 0.013 mM
0.015
2'-deoxyuridine 5'-(alpha,beta-imido)triphosphate
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000073
3-(2,2-difluoroethoxy)-N-(2-(4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)phenyl)propan-2-yl)-benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2,4,4-trimethylpentan-2-yl)propanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-methylbutan-2-yl)propanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-phenylethyl)propanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.022
3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(3-ethylhexan-3-yl)propanamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(3-phenylpropyl)propanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(diphenylmethyl)propanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000031
3-(cyclopentyloxy)-N-(2-(4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)phenyl)propan-2-yl)-benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000073
3-(cyclopropylmethoxy)-N-(2-(4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)phenyl)propan-2-yl)-benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.000035
3-(cyclopropylmethoxy)-N-[5-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy]-2-methylpentan-2-yl]benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0025
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(1-hydroxy-2-methyl-1,1-diphenylpropan-2-yl)butanamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(1-hydroxy-2-methylpropan-2-yl)butanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0013
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2,2-diphenylethyl)-N-methylbutanamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.016
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2,2-diphenylethyl)butanamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2,4,4-trimethylpentan-2-yl)butanamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0011
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-hydroxy-2,2-diphenylethyl)-N-methylbutanamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-methyl-1-phenylpropan-2-yl)butanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.021
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-methyl-4-phenylbutan-2-yl)butanamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(2-phenylpropan-2-yl)butanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(3-ethylpentan-3-yl)butanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(diphenylmethyl)butanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-phenylbutanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-[2-methyl-1-(naphthalen-2-yl)propan-2-yl]butanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
N,N-dibenzyl-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00127
N-(2-(4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-phenyl)propan-2-yl)-3-methoxybenzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0018
N-(2-(4-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-phenyl)propan-2-yl)benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.03
N-benzyl-4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)butanamide
Homo sapiens
IC50 above 0.03 mM, in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00004
N-[(1R)-1-[3-(cyclopropylmethoxy)phenyl]ethyl]-3-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy]propane-1-sulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.074
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]-D-alanyl-L-tyrosine
Trypanosoma cruzi
-
-
0.084
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]-L-alanyl-L-aspartic acid
Trypanosoma cruzi
-
-
0.081
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]-L-alanyl-L-glutamic acid
Trypanosoma cruzi
-
-
0.081
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]-L-alanyl-L-glutamine
Trypanosoma cruzi
-
-
0.081
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]-L-alanyl-L-lysine
Trypanosoma cruzi
-
-
0.087
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]-L-alanyl-L-threonine
Trypanosoma cruzi
-
-
0.1
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]-L-alanylglycine
Trypanosoma cruzi
-
-
0.084
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycyl-L-lysine
Trypanosoma cruzi
-
-
0.091
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycyl-L-threonine
Trypanosoma cruzi
-
-
0.076
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycyl-L-tyrosine
Trypanosoma cruzi
-
-
0.132
N-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycylglycine
Trypanosoma cruzi
-
-
0.00034
N-[2-[3-(cyclopropylmethoxy)phenyl]propan-2-yl]-3-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy]propane-1-sulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.0046
N-[3-(tert-butyl diphenyl silanyloxy)-propyl]-2-uracil acetamide
Plasmodium falciparum
-
above
0.0037
N-[4-(tert-butyl diphenyl silanyloxy)-butyl]-2-uracil acetamide
Plasmodium falciparum
-
above
0.0039
N-[5-[(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy]-2-methylpentan-2-yl]benzenesulfonamide
Homo sapiens
in 0.2 M Tris buffer (pH 7.4), 16 mM MgCl2, at 37°C
0.00003
Stl repressor protein from Staphylococcus aureus
Drosophila melanogaster
-
at pH 7.5 and 20°C
-
additional information
additional information
Trypanosoma cruzi
-
IC50 values of the inhibitor cytotoxicity assay on rat LC6 cells, overview
-